statistiche ricercatore

Continente	#
NA - Nord America	462
AS - Asia	404
EU - Europa	348
SA - Sud America	70
Continente sconosciuto - Info sul continente non disponibili	28
AF - Africa	15
OC - Oceania	2
Totale	1.329

Nazione	#
US - Stati Uniti d'America	436
IT - Italia	218
SG - Singapore	145
HK - Hong Kong	109
BR - Brasile	56
CN - Cina	45
VN - Vietnam	42
RU - Federazione Russa	38
DE - Germania	32
GB - Regno Unito	13
FR - Francia	12
IN - India	11
MX - Messico	11
BD - Bangladesh	10
ZA - Sudafrica	10
ID - Indonesia	8
CA - Canada	7
KR - Corea	7
FI - Finlandia	6
JP - Giappone	6
PK - Pakistan	6
AR - Argentina	5
IE - Irlanda	5
AT - Austria	4
BE - Belgio	4
TR - Turchia	4
CZ - Repubblica Ceca	3
EC - Ecuador	3
IQ - Iraq	3
JM - Giamaica	3
NL - Olanda	3
PL - Polonia	3
SE - Svezia	3
UA - Ucraina	3
MA - Marocco	2
MY - Malesia	2
SA - Arabia Saudita	2
VE - Venezuela	2
AU - Australia	1
BB - Barbados	1
CL - Cile	1
CO - Colombia	1
CY - Cipro	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
JO - Giordania	1
KI - Kiribati	1
KZ - Kazakistan	1
NI - Nicaragua	1
PR - Porto Rico	1
PY - Paraguay	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
VG - Isole Vergini Britanniche	1
Totale	1.301

Nome	#
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization	245
A Comprehensive In Vitro Characterization of a New Class of Indole-Based Compounds Developed as Selective Haspin Inhibitors	139
Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification	137
Metabolomics insights into the protective molecular mechanism of Vaccinium myrtillus against oxidative stress in intestinal cells	133
Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer	116
In Silico Identification and In Vitro Evaluation of New ABCG2 Transporter Inhibitors as Potential Anticancer Agents	113
NMR-based metabolomic profile of hypercholesterolemic human sera: Relationship with in vitro gene expression?	113
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization	112
Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation	111
Exploiting the Features of Short Peptides to Recognize Specific Cell Surface Markers	110
Totale	1.329

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	31	0	0	0	2	9	0	1	1	5	3	3	7
2022/2023	43	3	10	3	3	3	7	0	3	5	0	6	0
2023/2024	82	8	7	6	5	6	16	4	7	5	9	0	9
2024/2025	298	10	4	5	19	25	21	60	22	29	20	39	44
2025/2026	755	37	95	95	93	100	41	94	21	42	72	19	46
2026/2027	107	29	16	38	24	0	0	0	0	0	0	0	0
Totale													1.329

UniSa - IRIS Institutional Research Information System